Seeker Health Launches The Seeker Portal™, A Software Platform To Revolutionize Clinical Trial Enrollment, Drug Development And Human Health

Tuesday, November 7, 2017 Clinical Trials News
Email Print This Page Comment bookmark
Font : A-A+

New clinical trial patient lead management software helps accelerate clinical trial enrollment for serious or rare diseases

PALO ALTO, Calif., Nov. 7, 2017 /PRNewswire/ -- Seeker Health, a digital health company innovating the way that people

with serious diseases enroll in clinical trials, today announced the launch of the Seeker Portal™, the company's patent-pending clinical trial patient lead management software that helps evaluate, assign, manage and track participants to enrollment. Focused on the mantra that "Nothing Happens Without Patients™," Seeker Health is accelerating drug development by deploying compliant social media campaigns to improve patient education and using the Seeker Portal to accelerate the enrollment of participants into clinical studies for serious or rare diseases.

"Considering that much of the time a clinical trial runs, which averages two years, is spent on patient enrollment, finding ways to accelerate this effort is paramount," said Sandra Shpilberg, CEO & Founder. "At Seeker Health, we are using social media and technology like our Seeker Portal to solve this thorny problem and accelerate drug development so medicines get developed faster and reach those who need them earlier."

A clinical trial is the sole way that new medicines come to market. Patient enrollment is often cited by biopharmaceutical companies as one of the most significant barriers to conducting clinical trials and failure to enroll sufficient numbers of patients can result in costly delays or even cancellation of the entire trial. These barriers intensify in oncology and in rare diseases, where there is increased competition for participants.

The Seeker Portal is a secure and proprietary software-as-a-service platform developed by the Seeker Health engineering team with input from current customers and partners. Designed with the highest levels of data security and rigorous patient privacy guidelines, key features of the Seeker Portal include:

  • Secure and immediate delivery of qualified patient referrals to active clinical trial sites;
  • Evaluation of pre-screen patient submissions against set inclusion/exclusion criteria;
  • Immediate assignment of qualified patients to an active clinical site based on geographic analysis;
  • Immediate communication with qualified participants via email and text messaging;
  • Multi-language messaging capability for global clinical trials;
  • Real time tracking of referral lifecycle and progress toward enrollment;
  • Scalability of recruitment and enrollment efforts; and,
  • API integration with medical call centers.

The company currently works with drug developers and clinical research organizations and has successfully accelerated the enrollment of clinical trials for new medicines across numerous therapeutic areas, including oncology, women's health and rare diseases.

About the clinical trial processA clinical trial is the sole way that new medicines come to market. Mastering the process of finding, engaging and activating patients for enrollment into a clinical trial is a key success factor for all biopharmaceutical companies developing new treatments, yet many companies often struggle to find the required clinical trial participants within a given timeline. These delays result in additional development costs, but more importantly, the actual delay of treatments reaching those patients who need them most.

On any given day, there are more than 6,000 clinical trials running just in the U.S. involving more than a million patients.1 The total cost of a clinical trial is $13 million for Phase II and $20 million for Phase III, and the industry spends more than $5.9 billion in annual expenses on patient recruitment services.2 In fact, roughly 80 percent of clinical trials fail to meet enrollment timelines3, and approximately one-third (30 percent) of Phase III study terminations are due to enrollment difficulties. In addition, 15-to-20 percent of sites never enroll a single patient4.

About Seeker HealthSeeker Health brings innovation to global clinical trial enrollment helping accelerate the development of new medicines. Using technology and social media, Seeker Health helps medicines get developed faster and reach those who need them earlier with the mission of improving health outcomes around the world. For more information visit www.seekerhealth.com.

*Seeker Portal™ is the exclusive property of Seeker Health LLC. Patent pending. Seeker Health is a registered mark of Seeker Health LLC. All rights reserved.

1 http://phrma-docs.phrma.org/sites/default/files/pdf/biopharmaceutical-industry-sponsored-clinical-trials-impact-on-state-economies.pdf

2 https://www.cognizant.com/whitepapers/patients-recruitment-forecast-in-clinical-trials-codex1382.pdf

3 https://www.cognizant.com/whitepapers/patients-recruitment-forecast-in-clinical-trials-codex1382.pdf

4 http://phrma-docs.phrma.org/sites/default/files/pdf/biopharmaceutical-industry-sponsored-clinical-trials-impact-on-state-economies.pdf

 

View original content:http://www.prnewswire.com/news-releases/seeker-health-launches-the-seeker-portal-a-software-platform-to-revolutionize-clinical-trial-enrollment-drug-development-and-human-health-300550544.html

SOURCE Seeker Health



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store